News
Current position:Product Center > Antibodies > Biosimilar Antibodies
Kinase
Background

Kinase is a class of enzymes in biochemistry that transfer phosphate groups from high-energy donor molecules to specific target molecules, with the largest group being protein kinases. Kinases play a wide-ranging role in cellular signal transduction and the complex activities of life. Different kinases act on various small molecules, either to send signals or to prepare them for various biochemical reactions in metabolism.


Kinase is the most important class of targets in the development of anti-tumor drugs, such as the key targets ALK/ROS1 for non-small cell lung cancer, JAK2 for various malignant hematological tumors, and the popular target CDK9 for hematological tumors and lymphomas. Currently, significant breakthroughs have been made in the development of new drugs targeting ALK/ROS1, JAK2, and CDK9, with a number of small molecule kinase inhibitors being used in clinical treatment or entering clinical research. However, with the widespread use of kinase inhibitors, clinical issues such as acquired resistance and side effects have also emerged.


KINASE-2.png

Products
Target Cat. No Product
HER3(ERBB3)
GM-28859AB
Anti-H_HGFR(Met) hIgG4 Antibody(Emibetuzumab)
HER3(ERBB3)
GM-28858AB
Anti-H_ERBB3(HER3) hIgG1 Antibody(Barecetamab)
HER3(ERBB3)
GM-87129MAB
Anti-ERBB3(HER3) hIgG1 Reference Antibody(Patribio)
EGFR
GM-49155AB
Anti-H_EGFR hIgG1 Antibody(Necitumumab)
EGFR
GM-87800MAB
Anti-EGFR hIgG1 Reference Antibody (Cetbio)
EGFR
GM-87808MAB
Anti-EGFR hIgG1 Reference Antibody (Necbio)
HER2(ERBB2)
GM-49468AB
Anti-H_HER2 hIgG1 Antibody(Margetuximab)
CD117
GM-86542AB
Anti-c-Kit(CD117) hIgG1 Antibody(barzolvolimab)
CD117
GM-86543AB
Anti-c-Kit(CD117) hIgG1 Antibody(briquilimab)
CD117
GM-87809MAB
Anti-c-Kit(CD117)hIgG1 Reference Antibody(barbio)
MUSK
GM-87838AB
Anti-MUSK hIgG1 Antibody(3B2g2m1)
MUSK
GM-87841AB
Anti-MUSK mIgG2a Antibody(3B2g2m1)
HER2(ERBB2)
GM-87130MAB
Anti-HER2 hIgG1 Reference Antibody(Marbio)
HER2(ERBB2)
GM-87131MAB
Anti-HER2 hIgG1 Reference Antibody (Trasbio)
Product Center > Antibodies > Biosimilar Antibodies
classify
Kinase
Products
Target Cat. No Product
HER3(ERBB3)
GM-28859AB
Anti-H_HGFR(Met) hIgG4 Antibody(Emibetuzumab)
HER3(ERBB3)
GM-28858AB
Anti-H_ERBB3(HER3) hIgG1 Antibody(Barecetamab)
HER3(ERBB3)
GM-87129MAB
Anti-ERBB3(HER3) hIgG1 Reference Antibody(Patribio)
EGFR
GM-49155AB
Anti-H_EGFR hIgG1 Antibody(Necitumumab)
EGFR
GM-87800MAB
Anti-EGFR hIgG1 Reference Antibody (Cetbio)
EGFR
GM-87808MAB
Anti-EGFR hIgG1 Reference Antibody (Necbio)
HER2(ERBB2)
GM-49468AB
Anti-H_HER2 hIgG1 Antibody(Margetuximab)
CD117
GM-86542AB
Anti-c-Kit(CD117) hIgG1 Antibody(barzolvolimab)
CD117
GM-86543AB
Anti-c-Kit(CD117) hIgG1 Antibody(briquilimab)
CD117
GM-87809MAB
Anti-c-Kit(CD117)hIgG1 Reference Antibody(barbio)
MUSK
GM-87838AB
Anti-MUSK hIgG1 Antibody(3B2g2m1)
MUSK
GM-87841AB
Anti-MUSK mIgG2a Antibody(3B2g2m1)
HER2(ERBB2)
GM-87130MAB
Anti-HER2 hIgG1 Reference Antibody(Marbio)
HER2(ERBB2)
GM-87131MAB
Anti-HER2 hIgG1 Reference Antibody (Trasbio)
Background

Kinase is a class of enzymes in biochemistry that transfer phosphate groups from high-energy donor molecules to specific target molecules, with the largest group being protein kinases. Kinases play a wide-ranging role in cellular signal transduction and the complex activities of life. Different kinases act on various small molecules, either to send signals or to prepare them for various biochemical reactions in metabolism.


Kinase is the most important class of targets in the development of anti-tumor drugs, such as the key targets ALK/ROS1 for non-small cell lung cancer, JAK2 for various malignant hematological tumors, and the popular target CDK9 for hematological tumors and lymphomas. Currently, significant breakthroughs have been made in the development of new drugs targeting ALK/ROS1, JAK2, and CDK9, with a number of small molecule kinase inhibitors being used in clinical treatment or entering clinical research. However, with the widespread use of kinase inhibitors, clinical issues such as acquired resistance and side effects have also emerged.


KINASE-2.png

Tel: 400-627-9288
Message consultation
reset
submit
Service
WhatApp
Phone
Message
Message consultation
reset
submit